AI brain cancer prediction is revolutionizing the approach to managing pediatric gliomas, offering a promising solution for assessing the risk of relapse.Recent research from Harvard demonstrated that an AI tool surpasses traditional methods in forecasting cancer recurrence in children, significantly enhancing the accuracy of predictions based on multiple brain scans collected over time.